Triple agonist research peptide | Research grade | Lyophilised powder
Retatrutide (20mg)
Retatrutide for multi-agonist metabolic research models
Retatrutide is a synthetic peptide studied as a multi-agonist research compound in metabolic pathway literature. The Protocol supplies Retatrutide as a lyophilised powder strictly for laboratory and in vitro research.
Identity and purity are documented on Certificates of Analysis for verified lots. Confirm exact molecular parameters on your batch COA before protocol use.
For laboratory research purposes only. Not for human consumption. Not a medicine, supplement, or cosmetic. Intended for controlled laboratory and in vitro use only.
What it's for
Retatrutide is an investigational triple agonist (GLP-1 / GIP / glucagon). Clinical and research interest focuses on:
- Obesity and chronic weight-management clinical development
- Type 2 diabetes and glycemic-control research
- Metabolic dysfunction–associated steatotic liver disease (MASLD / MASH) trials
- Appetite regulation, energy expenditure, and body-composition studies
- Cardiometabolic risk-factor improvement research
- Head-to-head comparison with dual agonists such as tirzepatide in metabolic literature
Specifications
| Stock code | RT20 |
|---|---|
| Cap colour | Pink |
| Synonyms | LY3437943 (literature reference) |
| CAS number | 2381089-83-2 (confirm on batch COA) |
| Molecular weight | Approx. 4731 g/mol (as per batch COA) |
| Form | White to off-white lyophilised powder |
| Purity | ≥99.0% (COA validated) |
| Solubility | Soluble in sterile research solvents as per lab protocol |
| Quality checks | RP-HPLC identity/purity assessment; third-party verification where listed |
| Net content | 20mg per vial |
Storage and handling
- Store dry at 2–8°C unless your batch documentation states otherwise.
- Protect from moisture, light, and repeated temperature cycling.
- Reconstitute only under trained laboratory procedures using suitable sterile solvents.
- Follow your organisation’s SOPs for labelling, use, and disposal.
Calculate
Vial dilution lab-math
Acknowledgement required
Confirm the research-use acknowledgement to unlock controls and calculate.
Open full calculatorWhat is included
- 1 × Retatrutide, 20mg lyophilised vial
- Protective inner packing
- Access to batch-specific COA where available
- Australia Post tracking after dispatch
Quality signals
- ≥99% purity target with COA support
- Third-party laboratory verification on listed batches
- Tamper-evident packing checks before dispatch
- Clear product labelling for research inventory control
Product FAQ
Is this lab tested?+
Listed batches are assessed for purity and identity, with Certificates of Analysis available on request for verified lots.
How fast is Australian delivery?+
Express Australia Post typically runs 1 to 3 business days after dispatch, depending on destination.
Is outer packaging discreet?+
Yes. Outer cartons use plain labelling without product descriptors.
What is Retatrutide supplied for?+
Research inventory only. It is not for human or veterinary use, therapeutic procedures, or consumer applications.
This product and its description are intended solely for laboratory and controlled research use. Nothing on this page is medical advice, dosing guidance, or an invitation for personal use. Not for human consumption. See also the Research Use Disclaimer. For research purposes only. Not for human consumption. Not a medicine, supplement, or cosmetic. Laboratory and in vitro use only.